Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Gastroenterology|March 24, 2018
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 TrialGregory L Beatty, Mark H O'Hara, Simon F Lacey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected IndividualsJeffrey M Jacobson, Julie K Jadlowsky, Simon F Lacey, et al.
The Journal of Infectious Diseases|March 10, 2012
Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvantCorinna La Rosa, Jeff Longmate, Simon F Lacey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Science Translational Medicine|June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphomaDavid L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Blood|July 2, 2011
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceSimon F Lacey, Corinna La Rosa, Teodora Kaltcheva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
JCI Insight|January 12, 2018
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulationSonia Guedan, Avery D Posey, Carolyn Shaw, et al.
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Pageof 11